Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
- PublisherOxford University Press
- LanguageEnglish
- Article Processing ChargesGBP 2100
- Publication Time7
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- Society/Institute/SponsorBritish Society for Immunology
- Website URL
- Publication Time7
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC BY-NC
- OA statement
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Who is the publisher of Immunotherapy Advances? 
The publisher of Immunotherapy Advances is Oxford University Press.
How can I view the journal metrics of Immunotherapy Advances on editage? 
For the Immunotherapy Advances metrics, please refer to the section above on the page.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Antitumor response, Immune modulation, Clinical trial, VLA-4, Metabolic reprogramming, Antigen, B-cell lymphoma, Monoclonal antibody, Chimeric antigen receptor, Cancer immunotherapy, Steady state.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.